Obstructive sleep apnea is not an independent determinant of testosterone in men.


Journal

European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 10 12 2019
accepted: 29 04 2020
pubmed: 30 4 2020
medline: 17 6 2020
entrez: 30 4 2020
Statut: ppublish

Résumé

Obstructive sleep apnea (OSA) is generally considered to lower serum testosterone concentration in men, although data supporting this as a direct effect are limited. The aim of this study was to determine the relationship between the presence and severity of OSA and testosterone in a community-based cohort of men aged over 40 years. Anthropometry, polysomnography and biomedical information were collected from enrolled, consenting men from the prospective, longitudinal MAILES study cohort. Fasting morning blood samples (n = 1869) were drawn between 2010 and 2012 for measurement of testosterone using liquid chromatography mass spectrometry. Home polysomnography was completed in 861 men between 2010 and 2012. The final analysis sample consisted of 623 men aged 41-86 years. The effect of OSA on testosterone were analyzed using linear regression models controlling for potential confounders (age, BMI and sex hormone binding globulin (SHBG)). The mean (s.d.) cohort characteristics were: age 59.0 (10.2) years, testosterone 16.8 (5.3) nmol/L, SHBG 32.9 (13.1) nmol/L, BMI 28.6 (4.2) kg/m2 and apnoea hypopnoea index (AHI) 14.9 (13.7). OSA was present in 51.5%. There was an inverse relationship between AHI and testosterone (P = 0.01), which was lost after covariate adjustment. These data suggest that obesity, rather than OSA per se, determine testosterone concentration. This accords with the graded effect of weight loss, but limited effect of continuous positive airway pressure to increase testosterone, and highlights the importance of managing obesity in men with low testosterone concentration, particularly in the context of OSA.

Identifiants

pubmed: 32348955
doi: 10.1530/EJE-19-0978
pii: EJE-19-0978
doi:
pii:

Substances chimiques

Testosterone 3XMK78S47O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

31-39

Auteurs

Brigette Marie Clarke (BM)

Department of Endocrinology and Metabolism, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.

Andrew D Vincent (AD)

Freemason Foundation Centre for Men's Health, University of Adelaide, Adelaide, South Australia, Australia.

Sean Martin (S)

School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.
Freemason Foundation Centre for Men's Health, University of Adelaide, Adelaide, South Australia, Australia.

Robert Adams (R)

School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.
Adelaide Institute for Sleep Health: A Flinders Centre of Research Excellence, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Sarah Appleton (S)

School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.
Freemason Foundation Centre for Men's Health, University of Adelaide, Adelaide, South Australia, Australia.
Adelaide Institute for Sleep Health: A Flinders Centre of Research Excellence, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Andrew Vakulin (A)

Adelaide Institute for Sleep Health: A Flinders Centre of Research Excellence, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
NeuroSleep - NHMRC Centre of Research Excellence, Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.

David Jesudason (D)

Department of Endocrinology and Metabolism, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.
Department of Endocrinology and Diabetes, Queen Elizabeth Hospital, Woodville, South Australia, Australia.

Gary Allen Wittert (GA)

Department of Endocrinology and Metabolism, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.
Freemason Foundation Centre for Men's Health, University of Adelaide, Adelaide, South Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH